operations is an essential component of our business model to provide our clients the highest quality of service while ensuring delivery of their API on time and on schedule from a safe and environmentally friendly facility. As we increase our efficiencies with larger equipment, we also enhance our cost-effectiveness, further benefiting our customers," said Dr. Stephen Munk, President and CEO of Ash Stevens.
Subsequent phases of the expansion plan call for a new large-scale reactor bay, process development labs, and additional facilities to handle highly potent APIs.
For more information, visit Ash Stevens at CPhI Worldwide in Madrid, Spain, booth #NB403 located in the New Business Pavillion on October 16-19, 2009 or online at www.ashstevens.com. James M. Hamby, R.Ph., Ph.D., Vice President of Business Development for Ash Stevens, Inc. will be speaking on the topic of Managing CMC Development for FDA Fast-Tracked Drugs on Tuesday, October 13 at 2:00 p.m.
About Ash Stevens, Inc.
Headquartered in Detroit, Ash Stevens, Inc. (ASI) was founded in 1962 to service the chemical research needs of the Federal Government. ASI has extensive experience in the development and scale-up of commercial cancer APIs and shares a longstanding and successful relationship with the National Cancer Institute. ASI has a total of 11 FDA approved drug substances in its portfolio. The company has more than 60 employees and holds a variety of patents covering topics including medicinal agents and manufacturing processes. For more information, visit www.ashstevens.com.
###
Read the full story at http://www.prweb.com/releases/2009/09/prweb2966284.htm.
'/>"/>Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved | |
Page: 1 2 Related biology technology :1.
Ash Stevens Inc. Named One of Michigan 50 Companies to Watch2.
PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities3.
Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala4.
The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus5.
Stevens researchers provide new information about mass spectrometry6.
The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus7.
Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 138.
Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools9.
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications10.
Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.11.
Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres